These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36376741)

  • 1. Gender-Affirming Treatment of Gender Dysphoria in Youth: A Perfect Storm Environment for the Placebo Effect-The Implications for Research and Clinical Practice.
    Clayton A
    Arch Sex Behav; 2023 Feb; 52(2):483-494. PubMed ID: 36376741
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on Levine et al.: A Tale of Two Informed Consent Processes.
    Clayton A
    J Sex Marital Ther; 2023; 49(1):88-95. PubMed ID: 35531610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-Affirming Pharmacological Interventions for Youth With Gender Dysphoria: When Treatment Guidelines Are Not Enough.
    Nahata L; Chelvakumar G; Leibowitz S
    Ann Pharmacother; 2017 Nov; 51(11):1023-1032. PubMed ID: 28660776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician-Level Implications of Bans on Gender-Affirming Medical Care for Youth in the US.
    Warling A; Keuroghlian AS
    JAMA Pediatr; 2022 Oct; 176(10):963-964. PubMed ID: 35939318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
    Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
    J Sex Med; 2022 Jul; 19(7):1173-1184. PubMed ID: 35418328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic Response to Gender-Affirming Hormones Among Transgender Youth.
    Olson-Kennedy J; Okonta V; Clark LF; Belzer M
    J Adolesc Health; 2018 Apr; 62(4):397-401. PubMed ID: 29056436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgender and Gender Nonconforming Youth.
    Forcier M; Olson J
    Adolesc Med State Art Rev; 2014 Aug; 25(2):377-97. PubMed ID: 27132320
    [No Abstract]   [Full Text] [Related]  

  • 9. Midwifery Care for Transfeminine Individuals.
    Ellis SA; Dalke L
    J Midwifery Womens Health; 2019 May; 64(3):298-311. PubMed ID: 30957961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence?
    Masumori N; Baba T; Abe T; Niwa K
    Int J Urol; 2021 May; 28(5):526-529. PubMed ID: 33465834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pre-treatment IQ and educational achievement after gender-affirming treatment including puberty suppression in transgender adolescents.
    Arnoldussen M; Hooijman EC; Kreukels BP; de Vries AL
    Clin Child Psychol Psychiatry; 2022 Oct; 27(4):1069-1076. PubMed ID: 35638479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgender Youth Referred to Clinics for Gender-Affirming Medical Care in Canada.
    Bauer GR; Pacaud D; Couch R; Metzger DL; Gale L; Gotovac S; Mokashi A; Feder S; Raiche J; Speechley KN; Temple Newhook J; Ghosh S; Sansfaçon AP; Susset F; Lawson ML;
    Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34620727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
    van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
    J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affirming Gender Identity of Patients With Serious Mental Illness.
    Smith WB; Goldhammer H; Keuroghlian AS
    Psychiatr Serv; 2019 Jan; 70(1):65-67. PubMed ID: 30332928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
    Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
    Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invisibility of "Gender Dysphoria".
    Strand NK; Jones NL
    AMA J Ethics; 2021 Jul; 23(7):E557-562. PubMed ID: 34351266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual Treatment Progress Predicts Satisfaction With Transition-Related Care for Youth With Gender Dysphoria: A Prospective Clinical Cohort Study.
    Nieder TO; Mayer TK; Hinz S; Fahrenkrug S; Herrmann L; Becker-Hebly I
    J Sex Med; 2021 Mar; 18(3):632-645. PubMed ID: 33642235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults.
    Roberts CM; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3937-e3943. PubMed ID: 35452119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting Health Equality and Nondiscrimination for Transgender and Gender-Diverse Youth.
    Society for Adolescent Health and Medicine
    J Adolesc Health; 2020 Jun; 66(6):761-765. PubMed ID: 32473724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.